{"title":"日本妇女月经末期前后绝经症状的发生率:来自日本护士健康研究的数据","authors":"Tsuyoshi Higuchi , Yuki Ideno , Toshiyuki Yasui , Takumi Kurabayashi , Kiyoshi Takamatsu , Kazue Nagai , Kunihiko Hayashi","doi":"10.1016/j.maturitas.2025.108216","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To characterize various menopausal symptoms by examining their prevalence around the time of the final menstrual period (FMP).</div></div><div><h3>Study design</h3><div>The Japan Nurses' Health Study is a prospective cohort study on women's health. All participants, regardless of their age at the initial survey, were mailed a 4-year follow-up questionnaire that included questions on 21 climacteric symptoms. We analyzed 5189 Japanese women who completed the questionnaire 6 years before to 10 years after their FMP.</div></div><div><h3>Main outcome measures</h3><div>The prevalence of severe climacteric symptoms in the years before and after the time of the FMP (YFMP).</div></div><div><h3>Results</h3><div>Four distinct patterns were identified in the distribution of age-adjusted prevalence ratios by YFMP categories during menopausal transition. The prevalence of Group 1A symptoms (hot flashes, sweats, and poor memory or forgetfulness) was highest at the FMP and this continued through to the postmenopausal period. The prevalence of Group 1B symptoms was highest around the FMP but declined in the postmenopausal period. The independent effect of age was negatively significantly associated with most symptoms in Groups 1A and 1B, which suggested that younger women were more likely to have symptoms if they were in the same YFMP. In Group 2, the prevalence of symptoms did not increase. In Group 3, severe symptoms were rare.</div></div><div><h3>Conclusions</h3><div>Climacteric symptoms can be characterized according to their prevalence in the YFMP. The improved understanding of symptoms based on when they appear relative to the FMP could enable more detailed management of menopausal disorders and facilitate the prediction of changes in symptoms in Japanese women.</div></div>","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"195 ","pages":"Article 108216"},"PeriodicalIF":3.6000,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence of menopausal symptoms around the time of the final menstrual period in Japanese women: Data from the Japan Nurses' Health Study\",\"authors\":\"Tsuyoshi Higuchi , Yuki Ideno , Toshiyuki Yasui , Takumi Kurabayashi , Kiyoshi Takamatsu , Kazue Nagai , Kunihiko Hayashi\",\"doi\":\"10.1016/j.maturitas.2025.108216\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>To characterize various menopausal symptoms by examining their prevalence around the time of the final menstrual period (FMP).</div></div><div><h3>Study design</h3><div>The Japan Nurses' Health Study is a prospective cohort study on women's health. All participants, regardless of their age at the initial survey, were mailed a 4-year follow-up questionnaire that included questions on 21 climacteric symptoms. We analyzed 5189 Japanese women who completed the questionnaire 6 years before to 10 years after their FMP.</div></div><div><h3>Main outcome measures</h3><div>The prevalence of severe climacteric symptoms in the years before and after the time of the FMP (YFMP).</div></div><div><h3>Results</h3><div>Four distinct patterns were identified in the distribution of age-adjusted prevalence ratios by YFMP categories during menopausal transition. The prevalence of Group 1A symptoms (hot flashes, sweats, and poor memory or forgetfulness) was highest at the FMP and this continued through to the postmenopausal period. The prevalence of Group 1B symptoms was highest around the FMP but declined in the postmenopausal period. The independent effect of age was negatively significantly associated with most symptoms in Groups 1A and 1B, which suggested that younger women were more likely to have symptoms if they were in the same YFMP. In Group 2, the prevalence of symptoms did not increase. In Group 3, severe symptoms were rare.</div></div><div><h3>Conclusions</h3><div>Climacteric symptoms can be characterized according to their prevalence in the YFMP. The improved understanding of symptoms based on when they appear relative to the FMP could enable more detailed management of menopausal disorders and facilitate the prediction of changes in symptoms in Japanese women.</div></div>\",\"PeriodicalId\":51120,\"journal\":{\"name\":\"Maturitas\",\"volume\":\"195 \",\"pages\":\"Article 108216\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-02-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Maturitas\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0378512225000246\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GERIATRICS & GERONTOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Maturitas","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378512225000246","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
Prevalence of menopausal symptoms around the time of the final menstrual period in Japanese women: Data from the Japan Nurses' Health Study
Objective
To characterize various menopausal symptoms by examining their prevalence around the time of the final menstrual period (FMP).
Study design
The Japan Nurses' Health Study is a prospective cohort study on women's health. All participants, regardless of their age at the initial survey, were mailed a 4-year follow-up questionnaire that included questions on 21 climacteric symptoms. We analyzed 5189 Japanese women who completed the questionnaire 6 years before to 10 years after their FMP.
Main outcome measures
The prevalence of severe climacteric symptoms in the years before and after the time of the FMP (YFMP).
Results
Four distinct patterns were identified in the distribution of age-adjusted prevalence ratios by YFMP categories during menopausal transition. The prevalence of Group 1A symptoms (hot flashes, sweats, and poor memory or forgetfulness) was highest at the FMP and this continued through to the postmenopausal period. The prevalence of Group 1B symptoms was highest around the FMP but declined in the postmenopausal period. The independent effect of age was negatively significantly associated with most symptoms in Groups 1A and 1B, which suggested that younger women were more likely to have symptoms if they were in the same YFMP. In Group 2, the prevalence of symptoms did not increase. In Group 3, severe symptoms were rare.
Conclusions
Climacteric symptoms can be characterized according to their prevalence in the YFMP. The improved understanding of symptoms based on when they appear relative to the FMP could enable more detailed management of menopausal disorders and facilitate the prediction of changes in symptoms in Japanese women.
期刊介绍:
Maturitas is an international multidisciplinary peer reviewed scientific journal of midlife health and beyond publishing original research, reviews, consensus statements and guidelines, and mini-reviews. The journal provides a forum for all aspects of postreproductive health in both genders ranging from basic science to health and social care.
Topic areas include:• Aging• Alternative and Complementary medicines• Arthritis and Bone Health• Cancer• Cardiovascular Health• Cognitive and Physical Functioning• Epidemiology, health and social care• Gynecology/ Reproductive Endocrinology• Nutrition/ Obesity Diabetes/ Metabolic Syndrome• Menopause, Ovarian Aging• Mental Health• Pharmacology• Sexuality• Quality of Life